Technology | May 15, 2014

Mobile App Provides Life-Saving Assistance For Cardiac Patients

CathMaps+ debuts in Boston at AARP's Health [email protected]+ Tech Expo

CathMaps+ App Cath Lab Patient Engagement Mobile Devices

May 15, 2014 — CathMaps demonstrated how mobile technology can provide emergency assistance and peace of mind to millions of Americans at risk for a cardiac event. The AARP Health [email protected]+ Tech Expo showcases the latest in digital health technology designed to improve quality of life. The event is part of AARP's [email protected]+ National Event in Boston, May 8-10.

CathMaps+ is the world's first mobile application for people with elevated risk of a cardiac incident — particularly those who have a history of cardiac issues — that integrates critical health history and medical records with an interactive map of catheterization facilities (cath labs) throughout the world. The app is also HIPPA compliant.

"With the levels of heart disease on the rise in the U.S., the medical community must remain vigilant in our efforts to provide patients with tools and information that can help improve the quality of their lives," says Jack Stroh, an interventional cardiologist at Robert Wood Johnson University Hospital and St. Peter's University Hospital in New Jersey, and advisor to CathMaps+.

Approximately 715,000 Americans have a heart attack each year, according to the Centers for Disease Control. Nearly 30 percent of those have already suffered a heart attach. The CathMaps+ app ensures that patients quickly locate and are directed to a medical facility with a catheterization lab — wherever they may be traveling. They can securely access and share their medical history with the lab staff, saving critical time in treatment. They can also give permission for their information to be shared with loved ones, caregivers or emergency professionals.

"As a life or death condition, the idea of suffering a repeat incident is an almost constant concern. This app offsets patient anxiety, giving them peace of mind as they go about their daily lives," says Danny Oberman, founder and CEO of CathMaps+. "We see this as a valuable tool for cardiologist and the medical community as well. The AARP Health [email protected]+ Tech Expo is the perfect event to debut the app in the U.S."

Oberman founded CathMaps+ following his own cardiac incident in 2013. He combined his experience of living with an elevated risk of heart attack with his technology expertise to create a tool that is easy to use and functional in an emergency, while alleviating anxiety for cardiac patients.

CathMaps+, an Israeli-based technology company, is owned by Kickstart LLC, and is available for most Android and iOS users. The app is available in English and Spanish, with additional languages releases throughout 2014. It may be purchased from the App Store and Google Play.

For more information: www.cathmaps.com

Related Content

Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Infinix 4D CT

Toshiba's Infinix 4D CT, which combines CT with angiography in the interventional lab.

Feature | Angiography| September 28, 2016 | Tom Watson BS, RCVT, Clinical Analyst, MD Buyline
One of the more significant advancements for interventional X-ray (IXR) in the past few years has been a significantl
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab| September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 fi
Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award
News | Optical Coherence Tomography (OCT)| September 27, 2016
Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans...
Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons| September 26, 2016
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE...
smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
ACC, American College of Cardiology, Google search, heart conditions, Health Knowledge Graphs
News | Information Technology| September 23, 2016
A Google search for heart conditions will now prominently display important questions patients should ask their doctor...
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons| September 22, 2016
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency...
4Tech, TriCinch TTVR, transcather tricuspid valve repair device, first implant
News | Heart Valve Technology| September 22, 2016
4Tech Inc. announced that its TriCinch device has been used in the world’s first-ever successful transcatheter...
Overlay Init